Genetics assessment at the end of life: Suggestions for implementation in clinic and future research

John Martin Quillin, Joann N Bodurtha, Thomas J Smith

Research output: Contribution to journalArticle

Abstract

Background: Approximately 5%-10% of all cancers and cardiovascular diseases have a significant genetic component. Of the 15 most frequent admission diagnoses for palliative care, at least one third have a significant genetic component which is testable, informative, and potentially life saving to the survivors. Once the patient has died, the chance to test or bank DNA for common inherited conditions such as breast cancer, colon cancer, cardiovascular disease, etc., is gone. Objective: To determine the frequency of genetic conditions for commonly seen palliative care conditions, the availability of testing or DNA banking for future testing, and how genetics assessment is helpful. Design: A case illustration and review of the currently published evidence. Results: Genetic testing fits the accepted model of family-centered palliative care, is ethical, and may lead to life-saving interventions. Risk assessment tools and helpful websites are available. Conclusions: While common genetic conditions should be recognized before end-of-life care, the palliative care health professional may be the only person to recognize the condition before death of the patient and loss of available DNA.

Original languageEnglish (US)
Pages (from-to)451-458
Number of pages8
JournalJournal of Palliative Medicine
Volume11
Issue number3
DOIs
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

Palliative Care
Genetic Testing
Colonic Neoplasms
DNA
Cardiovascular Diseases
Terminal Care
Survivors
Breast Neoplasms
Health
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Genetics assessment at the end of life : Suggestions for implementation in clinic and future research. / Quillin, John Martin; Bodurtha, Joann N; Smith, Thomas J.

In: Journal of Palliative Medicine, Vol. 11, No. 3, 01.04.2008, p. 451-458.

Research output: Contribution to journalArticle

@article{439edb32509b4c79898b02d8d60df5fc,
title = "Genetics assessment at the end of life: Suggestions for implementation in clinic and future research",
abstract = "Background: Approximately 5{\%}-10{\%} of all cancers and cardiovascular diseases have a significant genetic component. Of the 15 most frequent admission diagnoses for palliative care, at least one third have a significant genetic component which is testable, informative, and potentially life saving to the survivors. Once the patient has died, the chance to test or bank DNA for common inherited conditions such as breast cancer, colon cancer, cardiovascular disease, etc., is gone. Objective: To determine the frequency of genetic conditions for commonly seen palliative care conditions, the availability of testing or DNA banking for future testing, and how genetics assessment is helpful. Design: A case illustration and review of the currently published evidence. Results: Genetic testing fits the accepted model of family-centered palliative care, is ethical, and may lead to life-saving interventions. Risk assessment tools and helpful websites are available. Conclusions: While common genetic conditions should be recognized before end-of-life care, the palliative care health professional may be the only person to recognize the condition before death of the patient and loss of available DNA.",
author = "Quillin, {John Martin} and Bodurtha, {Joann N} and Smith, {Thomas J}",
year = "2008",
month = "4",
day = "1",
doi = "10.1089/jpm.2007.0150",
language = "English (US)",
volume = "11",
pages = "451--458",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Genetics assessment at the end of life

T2 - Suggestions for implementation in clinic and future research

AU - Quillin, John Martin

AU - Bodurtha, Joann N

AU - Smith, Thomas J

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background: Approximately 5%-10% of all cancers and cardiovascular diseases have a significant genetic component. Of the 15 most frequent admission diagnoses for palliative care, at least one third have a significant genetic component which is testable, informative, and potentially life saving to the survivors. Once the patient has died, the chance to test or bank DNA for common inherited conditions such as breast cancer, colon cancer, cardiovascular disease, etc., is gone. Objective: To determine the frequency of genetic conditions for commonly seen palliative care conditions, the availability of testing or DNA banking for future testing, and how genetics assessment is helpful. Design: A case illustration and review of the currently published evidence. Results: Genetic testing fits the accepted model of family-centered palliative care, is ethical, and may lead to life-saving interventions. Risk assessment tools and helpful websites are available. Conclusions: While common genetic conditions should be recognized before end-of-life care, the palliative care health professional may be the only person to recognize the condition before death of the patient and loss of available DNA.

AB - Background: Approximately 5%-10% of all cancers and cardiovascular diseases have a significant genetic component. Of the 15 most frequent admission diagnoses for palliative care, at least one third have a significant genetic component which is testable, informative, and potentially life saving to the survivors. Once the patient has died, the chance to test or bank DNA for common inherited conditions such as breast cancer, colon cancer, cardiovascular disease, etc., is gone. Objective: To determine the frequency of genetic conditions for commonly seen palliative care conditions, the availability of testing or DNA banking for future testing, and how genetics assessment is helpful. Design: A case illustration and review of the currently published evidence. Results: Genetic testing fits the accepted model of family-centered palliative care, is ethical, and may lead to life-saving interventions. Risk assessment tools and helpful websites are available. Conclusions: While common genetic conditions should be recognized before end-of-life care, the palliative care health professional may be the only person to recognize the condition before death of the patient and loss of available DNA.

UR - http://www.scopus.com/inward/record.url?scp=41149113307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149113307&partnerID=8YFLogxK

U2 - 10.1089/jpm.2007.0150

DO - 10.1089/jpm.2007.0150

M3 - Article

C2 - 18363488

AN - SCOPUS:41149113307

VL - 11

SP - 451

EP - 458

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 3

ER -